Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
PainCeptor Pharma
About
PainCeptor Pharma Inc., a Montreal-based drug company focused on the treatment of chronic and acute pain.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $17.20M
- Industries
- Medical,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2004
- Number Of Employee
- 1 - 10
- Operating Status
- Active
PainCeptor Pharma is a pharmaceutical company developing next generation
therapeutic drugs for the treatment of chronic and acute pain. PainCeptor's
therapeutic programs are concentrated on some of the most promising, novel,
yet scientifically validated therapeutic targets within the PNS (peripheral
nervous system). By focusing on modulating target receptors in the PNS,
PainCeptor expects to enhance the efficacy and avoid the many detrimental side
effects associated with today's pain drugs which act primarily in the CNS
(central nervous system). PainCeptor's development pipeline includes two lead
antagonist programs, targeting NGF/p75-TrkA and ASIC1a, and a third antagonist
program targeting ASIC3.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 7, 2007 | Series B | $24.40M | 1 | — | — | Detail |
| Mar 22, 2004 | Series A | $17.20M | 1 |
CDP Capital Technology Ventures
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
CDP Capital Technology Ventures
|
— | Series B |
